Effectiveness of different treatment regimens on patients with COVID-19, hospitalized in Sanandaj hospitals: a retrospective cohort study

References

• Wani NClinical profile and outcome of covid positive obstetric patients in a tertiary care hospital-a retrospective studyOnline J Health Allied Sci202120310650
   Google Scholar
• Gautret P, Lagier J-C, Parola P, Meddeb L, Mailhe M, Doudier B, et al.Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInt J Antimicrob Agents2020561 1:CAS:528:DC%2BB3cXhsVOqt7vE https://doi.org/10.1016/j.ijantimicag.2020.105949
   Web of Science ®Google Scholar
• Jean S-S, Lee P-I, Hsueh P-RTreatment options for COVID-19: the reality and challengesJ Microbiol Immunol Infect2020533436443 1:CAS:528:DC%2BB3cXntFCmtb4%3D https://doi.org/10.1016/j.jmii.2020.03.034
   PubMedGoogle Scholar
• Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al.A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19N Engl J Med2020 https://doi.org/10.1056/NEJMoa2001282
   Web of Science ®Google Scholar
• Yu Q, Salvador CE, Melani I, Berg MK, Neblett EW, Kitayama SRacial residential segregation and economic disparity jointly exacerbate COVID-19 fatality in large American citiesAnn N Y Acad Sci2021 https://doi.org/10.1111/nyas.14567
   Web of Science ®Google Scholar
• Wissel BD, Van Camp PJ, Kouril M, Weis C, Glauser TA, White PS, et al.An interactive online dashboard for tracking COVID-19 in U.S. counties, cities, and states in real timeJ Am Med Inform Assoc202027711211125 https://doi.org/10.1093/jamia/ocaa071
   PubMed Web of Science ®Google Scholar
• Stasi C, Fallani S, Voller F, Silvestri CTreatment for COVID-19: An overviewEur J Pharmacol2020 https://doi.org/10.1016/j.ejphar.2020.173644
   PubMedGoogle Scholar
• Joshi S, Parkar J, Ansari A, Vora A, Talwar D, Tiwaskar M, et al.Role of favipiravir in the treatment of COVID-19Int J Infect Dis2021102501508 1:CAS:528:DC%2BB3cXisVGlsbvL https://doi.org/10.1016/j.ijid.2020.10.069
   PubMed Web of Science ®Google Scholar
• Cunningham AC, Goh HP, Koh DTreatment of COVID-19: old tricks for new challengesCrit Care202024191 https://doi.org/10.1186/s13054-020-2818-6
   PubMed Web of Science ®Google Scholar
• Ceylan ZEstimation of COVID-19 prevalence in Italy, Spain, and FranceSci Total Environ2020729 1:CAS:528:DC%2BB3cXot1Grt7c%3D https://doi.org/10.1016/j.scitotenv.2020.138817
   PubMed Web of Science ®Google Scholar
• Saba AI, Elsheikh AHForecasting the prevalence of COVID-19 outbreak in Egypt using nonlinear autoregressive artificial neural networksProcess Saf Environ Prot202014118 1:CAS:528:DC%2BB3cXhtVSjur3L https://doi.org/10.1016/j.psep.2020.05.029
   PubMed Web of Science ®Google Scholar
• Felsenstein S, Herbert JA, McNamara PS, Hedrich CMCOVID-19: immunology and treatment optionsClin Immunol2020215 1:CAS:528:DC%2BB3cXot1aqsbs%3D https://doi.org/10.1016/j.clim.2020.108448
   PubMed Web of Science ®Google Scholar
• Haider T, Gour V, Pandey V, Kanwar IL, Tiwari R, Vishwakarma M, et al.COVID-19 infection: targeting possibilities for treatment. Critical reviews™ in therapeutic drug carrier systemsCrit Rev Ther Drug Carrier Syst202138375115 https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2021035392
   PubMed Web of Science ®Google Scholar
• Magagnoli J, Narendran S, Pereira F, Cummings TH, Hardin JW, Sutton SS, et al.Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19Med20201111 https://doi.org/10.1016/j.medj.2020.06.001
   PubMedGoogle Scholar
• Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, et al.Remdesivir for the treatment of COVID-19Cochrane Database Syst Rev202188CD014962 https://doi.org/10.1002/14651858.CD014962
   PubMedGoogle Scholar
• Nojomi M, Yassin Z, Keyvani H, Makiani MJ, Roham M, Laali A, et al.Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trialBMC Infect Dis2020201110 https://doi.org/10.1186/s12879-020-05698-w
   Web of Science ®Google Scholar
• Chibber P, Haq SA, Ahmed I, Andrabi NI, Singh GAdvances in the possible treatment of COVID-19: a reviewEur J Pharmacol2020883 1:CAS:528:DC%2BB3cXhsVeru7jJ https://doi.org/10.1016/j.ejphar.2020.173372
   PubMed Web of Science ®Google Scholar
• Assiri A, Iqbal MJ, Mohammed A, Alsaleh A, Assiri A, Noor A, et al.COVID-19 related treatment and outcomes among COVID-19 ICU patients: a retrospective cohort studyJ Infect Public Health202114912741278 https://doi.org/10.1016/j.jiph.2021.08.030
   PubMed Web of Science ®Google Scholar
• Ismail A, Jamil AT, Rahman AFA, Bakar JMA, Saad NM, Saadi HThe implementation of Hospital Information System (HIS) in tertiary hospitals in Malaysia: a qualitative studyMalays J Public Health Med20101021624
   PubMedGoogle Scholar
• Ye Z, Wang Y, Colunga-Lozano LE, Prasad M, Tangamornsuksan W, Rochwerg B, et al.Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysisCMAJ202019227E756E767 1:CAS:528:DC%2BB3cXhtlGktLbM https://doi.org/10.1503/cmaj.200645
   PubMed Web of Science ®Google Scholar
• Lagier J-C, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, et al.Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: a retrospective analysisTravel Med Infect Dis202036 https://doi.org/10.1016/j.tmaid.2020.101791
   Web of Science ®Google Scholar
• Vahedi E, Ghanei M, Ghazvini A, Azadi H, Izadi M, Panahi Y, et al.The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational studyDARU J Pharm Sci2020282507516 https://doi.org/10.1007/s40199-020-00353-w
   Web of Science ®Google Scholar
• Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, et al.Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York StateJAMA20203232424932502 1:CAS:528:DC%2BB3cXhtlSnt7jO https://doi.org/10.1001/jama.2020.8630
   PubMed Web of Science ®Google Scholar
• Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al.Observational study of hydroxychloroquine in hospitalized patients with Covid-19N Engl J Med20203822524112418 1:CAS:528:DC%2BB3cXht1Gmsb3N https://doi.org/10.1056/NEJMoa2012410
   PubMed Web of Science ®Google Scholar
• Arshad S, Kilgore P, Chaudhry ZS, Jacobsen G, Wang DD, Huitsing K, et al.Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19Int J Infect Dis202097396403 1:CAS:528:DC%2BB3cXhtl2qsr%2FO https://doi.org/10.1016/j.ijid.2020.06.099
   PubMed Web of Science ®Google Scholar
• Garibaldi BT, Wang K, Robinson ML, Zeger SL, Bandeen-Roche K, Wang M-C, et al.Comparison of time to clinical improvement with vs without remdesivir treatment in hospitalized patients with COVID-19JAMA Netw Open202143e213071 https://doi.org/10.1001/jamanetworkopen.2021.3071
   PubMed Web of Science ®Google Scholar
• Tong S, Su Y, Yu Y, Wu C, Chen J, Wang S, et al.Ribavirin therapy for severe COVID-19: a retrospective cohort studyInt J Antimicrob Agents2020563 1:CAS:528:DC%2BB3cXhsFeju7fE https://doi.org/10.1016/j.ijantimicag.2020.106114
   PubMed Web of Science ®Google Scholar
• Bahl A, Johnson S, Chen N-WTiming of corticosteroids impacts mortality in hospitalized COVID-19 patientsIntern Emerg Med202116615931603 https://doi.org/10.1007/s11739-021-02655-6
   PubMed Web of Science ®Google Scholar
• Li J, Liao X, Zhou Y, Wang L, Yang H, Zhang W, et al.Comparison of associations between glucocorticoids treatment and mortality in COVID-19 patients and SARS patients: a systematic review and meta-analysisShock2021562215228 1:CAS:528:DC%2BB3MXhslersb3L https://doi.org/10.1097/SHK.0000000000001738
   PubMed Web of Science ®Google Scholar
• Zhong H, Wang Y, Zhang Z-L, Liu Y-X, Le K-J, Cui M, et al.Efficacy and safety of current therapeutic options for COVID-19-lessons to be learnt from SARS and MERS epidemic: a systematic review and meta-analysisPharmacol Res2020157 1:CAS:528:DC%2BB3cXhtVels7fJ https://doi.org/10.1016/j.phrs.2020.104872
   PubMed Web of Science ®Google Scholar
• Hassanipour S, Arab-Zozani M, Amani B, Heidarzad F, Fathalipour M, Martinez-de-Hoyo RThe efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trialsSci Rep2021111111 https://doi.org/10.1038/s41598-021-90551-6
   PubMed Web of Science ®Google Scholar
• Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, et al.Tocilizumab for treatment of mechanically ventilated patients with COVID-19Clin Infect Dis2021732e445e454 1:CAS:528:DC%2BB3MXhs1Wqur7I https://doi.org/10.1093/cid/ciaa954
   PubMed Web of Science ®Google Scholar
• Guner R, Hasanoglu I, Kayaaslan B, Aypak A, Akinci E, Bodur H, et al.Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravirJ Infect Public Health2021143365370 https://doi.org/10.1016/j.jiph.2020.12.017
   PubMed Web of Science ®Google Scholar
• Adeli M, Fesharaki MGEvaluation of COVID-19 treatment outcomes in a military hospital and its comparison with a nonmilitary hospitalJournal Mil Med2021238675683
   Google Scholar
• Keller MJ, Kitsis EA, Arora S, Chen JT, Agarwal S, Ross MJ, et al.Effect of systemic glucocorticoids on mortality or mechanical ventilation in patients with COVID-19J Hosp Med2020158489493 https://doi.org/10.12788/jhm.3497
   PubMed Web of Science ®Google Scholar
• Almazrou SH, Almalki ZS, Alanazi AS, Alqahtani AM, Alghamd SMComparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: a retrospective cohort studySaudi Pharmaceutical Journal2020281218771882 1:CAS:528:DC%2BB3MXlt1Wgtg%3D%3D https://doi.org/10.1016/j.jsps.2020.09.019
   PubMed Web of Science ®Google Scholar